Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Global Emerging Markets (GEM) is a $3.4 billion alternative investment group founded in 1991. It manages a diverse set of investment vehicles focused on emerging markets across the world, with a diversified portfolio of asset classes spanning the global private investing spectrum. GEM's investment vehicles provide exposure to small-mid cap management buyouts, private investments in public equities (PIPEs), and select venture investments. The firm has offices in New York, Paris, and Nassau, Bahamas.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Global Emerging Markets Group (GEM)'s primary investment focus?
- Global Emerging Markets Group (GEM) primarily focuses on the Health Tech & Life Sciences sector, with its sole disclosed portfolio company, POCARED Diagnostics, operating in this area.
- When did Global Emerging Markets Group (GEM) make its most recent disclosed investment?
- Global Emerging Markets Group (GEM)'s most recent disclosed investment occurred in July 2021.
- Can you name a notable company in Global Emerging Markets Group (GEM)'s portfolio?
- A notable company in Global Emerging Markets Group (GEM)'s portfolio is POCARED Diagnostics, which develops automated, reagent-free microorganism detection technology.
- What is the typical investment range for Global Emerging Markets Group (GEM)?
- Global Emerging Markets Group (GEM) typically invests in the range of $50M.
- What is the total amount raised by POCARED Diagnostics, a Global Emerging Markets Group (GEM) portfolio company?
- POCARED Diagnostics, a portfolio company of Global Emerging Markets Group (GEM), has raised $103.38M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Global Emerging Markets |
|---|---|
| Founded | 1991 |